First Citizens Bank & Trust CO Illumina, Inc. Transaction History

First Citizens Bank & Trust CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 12, 2019	SELL	$272.57 - $321.18 $914,472 - $1.08 Million	-3,355 Closed	0 $0
Q4 2018 Jan 15, 2019	SELL	$272.46 - $366.54 $512,224 - $689,095	-1,880 Reduced 35.91%	3,355 $1.01 Million
Q3 2018 Oct 18, 2018	BUY	$279.04 - $367.06 $3,348 - $4,404	12 Added 0.23%	5,235 $1.92 Million
Q2 2018 Jul 11, 2018	BUY	$228.17 - $292.07 $88,301 - $113,031	387 Added 8.0%	5,223 $1.46 Million
Q1 2018 Apr 11, 2018	BUY	$209.54 - $253.91 $13,620 - $16,504	65 Added 1.36%	4,836 $1.14 Million
Q4 2017 Jan 10, 2018	BUY	$202.23 - $230.03 $22,447 - $25,533	111 Added 2.38%	4,771 $1.04 Million
Q3 2017 Oct 12, 2017	BUY	$172.3 - $213.93 $802,918 - $996,913	4,660	4,660 $928,000

969

151M

2.37M

1.41M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $12.6B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of First Citizens Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on First Citizens Bank & Trust CO with notifications on news.